Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Taro Pharmaceutical Industries Ltd. | Haifa Bay, Israel | Makes it | No problems foundDec 8, 2022 · 7 inspections |
Recalls
- Dec 20, 2019 · Class I · Taro Pharmaceuticals U.S.A., Inc.
Cross Contamination; Lamotrigine Tablets 100 mg USP was contaminated with enalapril maleate.
Lots: Lot #: 331771, Exp. June 2021
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lamotrigine: every company that makes it
- Form
- tablet, oral
- Strength
- 200 mg
- Approval
- ANDA ANDA078525
- On the market since
- Jan 27, 2009
- Package NDCs
51672-4133-051672-4133-151672-4133-251672-4133-351672-4133-451672-4133-6- Official label
- DailyMed (National Library of Medicine), updated Jun 3, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?